Table 1. . Participant characteristics.

Variable	Participants (n = 32)	Nonparticipants† (n = 9)
Sex, n (%)
Female	22 (69)	9 (100)
Male	10 (31)	0 (0)
Ethnicity, n (%)
Hispanic/Latinx	6 (19)	2 (22)
Non-Hispanic/Non-Latinx	26 (81)	7 (78)
Race, n (%)
Black or African–American	20 (63)	6 (67)
Asian	5 (16)	1 (11)
American Indian or Alaska Native	3 (9)	1 (11)
Native Hawaiian or Other Pacific Islander	1 (3)	0 (0)
More than one race, n (%)
Black or African–American and American Indian or Alaska Native	1 (3)	0 (0)
Black or African–American, Asian and American Indian or Alaska Native	0 (0)	1 (11)
Asian and Native Hawaiian or Other Pacific Islander	2 (6)	0 (0)
Age at diagnosis, n (%)
Teens	3 (9)	1 (11)
20s	14 (44)	4 (44)
30s	15 (47)	4 (44)
Cancer diagnosis, n (%)
Breast	10 (31)	2 (22)
Stomach	3 (9)	0 (0)
Hodgkin's lymphoma	2 (6)	1 (11)
Non-Hodgkin's lymphoma	3 (9)	0 (0)
Cervical	2 (6)	2 (22)
Leukemia	4 (13)	1 (11)
Multiple cancer types	3 (9)	0 (0)
Other carcinomas/types‡	5 (16)	3 (33)
Education, n (%)
High school diploma or equivalent	5 (16)	1 (11)
Some college	2 (6)	3 (33)
College degree	15 (47)	4 (44)
Graduate degree	10 (31)	1 (11)
Household income, n (%)
Less than US$24,999	2 (6)	1 (11)
US$25,000–49,999	7 (22)	2 (22)
US$50,000–74,999	9 (28)	3 (33)
US$75,000 and greater	12 (38)	1 (11)
Prefer not to answer	2 (6)	2 (22)

41 Black, Indigenous and People of Color adolescent and young adult patients were initially recruited as expert participants; nine were lost to attrition between survey rounds and excluded from the final electronic Delphi panel of Black, Indigenous and People of Color adolescent and young adult patient experts (n = 32).

^†Lost to attrition between survey rounds.

^‡Includes liver, oral and meningioma brain tumor.